Gummies are the biggest hemp-derived THC format by volume, and the one most people mean when they talk about the November change. The rule that hits them is short, and the important word is easy to skim past.
The rule
Section 781 of Public Law 119-37 excludes from the federal definition of hemp any final hemp-derived cannabinoid product containing:
“greater than 0.4 milligrams combined total per container of… total tetrahydrocannabinols (including tetrahydrocannabinolic acid); and any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).”
Effective 365 days after the Act was signed on 12 November 2025. So 12 November 2026.
Per container. Not per gummy.
This is the detail that decides the outcome.
If the limit were per piece, a brand could shrink the dose and sell more pieces. Because it is per container, the whole bag counts. A bag of twenty 5mg gummies carries 100mg. The limit is 0.4mg for the bag.
To comply, a container would need to hold less THC in total than a single conventional gummy contains on its own. You cannot get there by making the gummies weaker, because you would need roughly one four-hundredth of the current total, and at that point you are selling candy with a rounding error in it.
The substitution route is closed too
The instinct in the industry has been to reach for a different cannabinoid whenever one gets restricted. Delta-8 when delta-9 was limited, then others after that.
The statute anticipates it. The cap is a combined total covering THC plus other cannabinoids with similar effects, and it explicitly includes cannabinoids “marketed to have similar effects”. So the reformulation that keeps the experience and changes the molecule lands in the same limit once HHS makes its determination.
Two other clauses close the remaining gaps. Products are excluded if they contain cannabinoids not capable of being naturally produced by the plant, and also if they contain cannabinoids that could be naturally produced but were synthesized or manufactured outside it. That second one describes how most alternative cannabinoids are actually made.
What survives
Genuinely low-dose products that fit under the cap. There is a real, if small, category there.
CBD gummies, provided the combined total stays under the limit. Worth checking on full-spectrum formulas, which by design carry minor cannabinoids.
And products that were never selling intoxication in the first place. That category is bigger than the industry usually admits. Plenty of people buy for the flavor, the ritual, or the aromatic character rather than the effect, and none of that depends on a cannabinoid limit. If you are working out what you actually want, how to choose sensibly is a more useful starting point than a milligram number.
On the proposed delay
The Senate released continuing resolution text on 2 August 2026 that would move most of these restrictions to 11 December 2026. As of 4 August 2026 it had not passed the Senate, had not passed the House, and had not been signed.
If it passes, gummies get about four extra weeks. The structural problem does not change, and it returns with the next funding deadline.
The blunt version
A 0.4mg per container cap is not a restriction on hemp gummies. It is the end of the intoxicating hemp gummy as a federal product, unless Congress passes something different before the date. Anyone telling you their bag will comply after 12 November is either planning a very different product or has not read the container clause.
A note on what this is
This is a plain-English summary written on 4 August 2026 and checked against the primary documents rather than against other coverage. It is not legal advice, and it is not medical advice. Rules in this area move quickly, so check the date at the top before you rely on any of it.
